Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 37.66M P/E - EPS this Y - Ern Qtrly Grth -
Income -80.61M Forward P/E -4.48 EPS next Y - 50D Avg Chg 2.00%
Sales 30.26M PEG - EPS past 5Y - 200D Avg Chg 22.00%
Dividend N/A Price/Book 0.32 EPS next 5Y - 52W High Chg -43.00%
Recommedations 2.00 Quick Ratio 0.19 Shares Outstanding 7.01M 52W Low Chg 81.00%
Insider Own 59.84% ROA -7.85% Shares Float 2.85M Beta -
Inst Own 2.67% ROE -81.29% Shares Shorted/Prior 12.64K/14.40K Price 0.27
Gross Margin -0.61% Profit Margin -266.40% Avg. Volume 655,153 Target Price 27.60
Oper. Margin -44.08% Earnings Date Mar 29 Volume 89,732 Change 3.27%
About DSS, Inc.

DSS, Inc. operates in the product packaging, biotechnology, direct, commercial lending, securities and investment management, alternative trading, digital transformation, secure living, and alternative energy businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. The company also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, it focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services, as well as digital transformation services; operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers; and develops healthy living communities. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as operates as a digital assets broker dealer; and offers solar farms, solar battery banks, and residential energy creation and storage services. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.

DSS, Inc. News
01/30/24 Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."
01/04/24 DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market
12/22/23 DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan
09:12 AM DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction
08:10 AM Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years
11/15/23 Impact Biomedical Inc. Files Current Report on Form 8-K
11/14/23 DSS Inc. Wins Patent Dispute with Nichia Corporation
11/08/23 DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock
10/26/23 DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule
10/23/23 DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical
10/12/23 DSS Inc. Issues Letter to Shareholders
09/06/23 DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary
08/29/23 DSS Cuts Losses Significantly By Exiting Direct Marketing
07/31/23 DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.
07/05/23 DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.
06/30/23 DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.
06/26/23 DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend
06/13/23 Presenting on the Emerging Growth Conference on June 14 Register Now
05/17/23 DSS: Sharing Services’ Q1 Spin-Off to Be Followed By Impact Biomedical
05/16/23 DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
DSS Chatroom

User Image johannn Posted - 21 hours ago

$DSS The DSS annual report is strange that the professional posters who would normally do this no longer do so. https://www.sec.gov/Archives/edgar/data/771999/000149315224011519/form10-k.htm

User Image RollingDollar Posted - 2 days ago

$DSS

User Image maplelakeduckslayer Posted - 5 days ago

$DSS people posting these weird unknown sites showing the IPO is next week when they can look directly at the NYSE website and clearly see there is no impact biomedical IPO next week. Not to mention no sec filings giving a date. But yeah believe some website no one uses

User Image Derfaber77 Posted - 6 days ago

$DSS The right representation of this scam or pile of shit. The number of the beast 😂

User Image RollingDollar Posted - 6 days ago

$DSS

User Image drjdc Posted - 6 days ago

$DSS March 29th Impact Bio IPO??

User Image RollingDollar Posted - 6 days ago

$DSS

User Image RollingDollar Posted - 1 week ago

$DSS

User Image RollingDollar Posted - 1 week ago

$DSS

User Image Derfaber77 Posted - 1 week ago

$DSS Honestly speaking what are the next moves of this scam? Movements are now absent, no significant news and we are on the verge of bankruptcy. Delisting, voluntary OTC, total liquidation? Anything they created other than a game of worthless Chinese boxes I honestly don't see. Business completely absent. I wonder how the SEC can get all this rubbish listed on an official stock exchange

User Image RollingDollar Posted - 1 week ago

$DSS

User Image urionz80 Posted - 1 week ago

$DSS did you notice they removed business units? it has been quite some time now. not that m shocked.

User Image Finanz Posted - 1 week ago

$DSS When is this Impact Biomedical IPO going to be one? $PRPH news referenced Equivir, which was licensed from Impact Biomedical, which DSS owns a good bit of. Equivir Initial Trial Results Indicate Potential Breakthrough in Respiratory Health: Equivir, another subsidiary under ProPhase Labs, Inc., has achieved significant milestones in its clinical development. The subsidiary successfully completed enrollment of over 329 patients, with the last participant starting at the beginning of 2024. Interim results from the first 152 patients at the 90-day mark have been particularly promising. The data revealed that 68% of the total number of upper respiratory incidents occurred in the placebo group, compared to only 32% in the Equivir group, indicating a strong potential for Equivir in potentially reducing upper respiratory incidents. The initial data surpassed expectations, with the full dataset expected to be available by the end of June 2024.

User Image johannn Posted - 1 week ago

$DSS For those who missed the Equivir story, here is the repeat. Use the Slide list button to go directly to Equivir. https://renmark-drupal.s3.amazonaws.com/vndr/ProPhase-Labs-Inc/2024-03-15-11-00-00/index.html

User Image johannn Posted - 1 week ago

$DSS In 15 minutes the Prophase Conference Call will start, maybe he will tell you something about Equivir. https://www.renmarkfinancial.com/events/fourth-quarter-year-end-2023-results-virtual-conference-call-nasdaq-prph-2024-03-15-110000

User Image RollingDollar Posted - 1 week ago

$DSS

User Image RollingDollar Posted - 1 week ago

$DSS

User Image RollingDollar Posted - 2 weeks ago

$DSS

User Image RollingDollar Posted - 2 weeks ago

$DSS

User Image RollingDollar Posted - 2 weeks ago

$DSS

User Image RollingDollar Posted - 2 weeks ago

$DSS

User Image johannn Posted - 2 weeks ago

$DSS $SHRG Not that I thought about it for a second, but according to my European broker SAXO I cannot buy additional Sharing Services Global Corporation (SHRG) shares, but I can still sell them.😁 No reason was given, are there other people who have received such a report?

User Image traderbozz Posted - 2 weeks ago

$DSS I have 15000 shares of IBO , the offer range is between $3-5 does that mean I have $45k Worth ?

User Image Ymalina Posted - 2 weeks ago

$DSS are we going to be able to sell Impact shares right away?

User Image Powerbattles Posted - 2 weeks ago

$DSS Finally coming soon.

User Image dkschill Posted - 2 weeks ago

$DSS is it true?? Chan is under investigation for his deceptive practices??

User Image RollingDollar Posted - 2 weeks ago

$DSS

User Image JCJ99 Posted - 2 weeks ago

$DSS oleeee. They will have to pump it before 3-29. I think the exchange will be 4 Bio x 1 Dss

User Image Dvosee Posted - 3 weeks ago

$DSS I like when Rolling Dollar says “$DSS”

User Image RollingDollar Posted - 3 weeks ago

$DSS

Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Chan Heng Fai Ambrose Director Director Dec 28 Buy 0.146 672,173 98,137 19,586,499 01/02/24
Chan Heng Fai Ambrose Director Director Dec 13 Buy 0.2266 334,921 75,893 18,914,326 12/14/22
Wu William Wai Leung Director Director Jun 16 Buy 0.38 10,000 3,800 151,020 06/21/22
Wu William Wai Leung Director Director Jun 07 Buy 0.41 140,000 57,400 140,000 06/14/22
Chan Heng Fai Ambrose Director Director Mar 09 Buy .381 3,986,877 1,519,000 26,178,632 03/10/22